Comparison Between Recombinant Versus Urinary hCG for Ovulation Induction in High Responders
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00415766|
Recruitment Status : Unknown
Verified January 2016 by Eugonia.
Recruitment status was: Active, not recruiting
First Posted : December 25, 2006
Last Update Posted : January 20, 2016
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Actual Primary Completion Date :||December 2015|
|Estimated Study Completion Date :||July 2016|
Revelli A, Poso F, Gennarelli G, Moffa F, Grassi G, Massobrio M. Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis. Reprod Biol Endocrinol. 2006 Jul 18;4:38.